MA39951A - Détection de l'adn provenant d'un type spécifique de cellule et méthodes associées - Google Patents

Détection de l'adn provenant d'un type spécifique de cellule et méthodes associées

Info

Publication number
MA39951A
MA39951A MA039951A MA39951A MA39951A MA 39951 A MA39951 A MA 39951A MA 039951 A MA039951 A MA 039951A MA 39951 A MA39951 A MA 39951A MA 39951 A MA39951 A MA 39951A
Authority
MA
Morocco
Prior art keywords
dna
methods
originates
detection
cells
Prior art date
Application number
MA039951A
Other languages
English (en)
Inventor
Sebastian Grömminger
Wera Hofmann
Matthias Sachse
Hamed Said
Original Assignee
Lifecodexx Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP14167769.0A external-priority patent/EP2942400A1/fr
Priority claimed from EP14167775.7A external-priority patent/EP2942401A1/fr
Application filed by Lifecodexx Ag filed Critical Lifecodexx Ag
Publication of MA39951A publication Critical patent/MA39951A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6827Hybridisation assays for detection of mutation or polymorphism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/154Methylation markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Medical Informatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)

Abstract

La présente invention concerne des méthodes permettant de détecter une quantité d'adn qui provient de cellules d'un type donné, l'échantillon comprenant un tel adn mélangé avec de l'adn qui ne provient pas de telles cellules. De telles méthodes sont basées sur une méthylation différentielle, au niveau de certaines régions, de l'adn qui provient du type donné de cellules par comparaison avec l'adn mélangé. De telles méthodes peuvent être appliquées en particulier à la détection, à partir d'un liquide biologique provenant d'une femme enceinte, de l'adn acellulaire provenant d'un fœtus ou du placenta d'un fœtus, ou à la détection, à partir d'un liquide biologique provenant d'un individu, de l'adn acellulaire provenant de cellules d'une tumeur. Par conséquent, de telles méthodes ont une utilité diagnostique, pronostique et/ou prédictive pour détecter un risque accru d'un individu souffrant d'un état de santé tel qu'une prééclampsie ou un cancer ou de développer celui-ci, et/ou pour faciliter des méthodes (ultérieures) diagnostiques, pronostiques et/ou prédictives telles que la détection de la trisomie chromosomique dans un fœtus, y compris des grossesses gémellaires. La présente invention concerne également des compositions, des kits, des produits-programmes informatiques et d'autres aspects qui sont utilisés dans la pratique de telles méthodes, utiles pour celle-ci ou associés à celle-ci.
MA039951A 2014-05-09 2015-05-08 Détection de l'adn provenant d'un type spécifique de cellule et méthodes associées MA39951A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14167769.0A EP2942400A1 (fr) 2014-05-09 2014-05-09 Détection multiplexe d'ADN qui provient d'un type cellulaire spécifique
EP14167775.7A EP2942401A1 (fr) 2014-05-09 2014-05-09 Détection d'ADN qui provient d'un type cellulaire spécifique

Publications (1)

Publication Number Publication Date
MA39951A true MA39951A (fr) 2017-03-15

Family

ID=53189029

Family Applications (1)

Application Number Title Priority Date Filing Date
MA039951A MA39951A (fr) 2014-05-09 2015-05-08 Détection de l'adn provenant d'un type spécifique de cellule et méthodes associées

Country Status (11)

Country Link
US (2) US10801067B2 (fr)
EP (2) EP3521454A1 (fr)
JP (1) JP6681841B2 (fr)
CN (1) CN107223159A (fr)
AU (1) AU2015257654A1 (fr)
CA (1) CA2985134A1 (fr)
IL (1) IL248637A0 (fr)
MA (1) MA39951A (fr)
RU (1) RU2016147914A (fr)
SG (1) SG11201608993RA (fr)
WO (1) WO2015169947A1 (fr)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190010543A1 (en) 2010-05-18 2019-01-10 Natera, Inc. Methods for simultaneous amplification of target loci
US11939634B2 (en) 2010-05-18 2024-03-26 Natera, Inc. Methods for simultaneous amplification of target loci
BR112013020220B1 (pt) 2011-02-09 2020-03-17 Natera, Inc. Método para determinar o estado de ploidia de um cromossomo em um feto em gestação
EP3544015B1 (fr) 2012-02-03 2024-10-23 California Institute of Technology Codage ou décodage de signaux dans des dosages biochimiques multiplexés
EP3901243A1 (fr) 2012-08-03 2021-10-27 California Institute of Technology Multiplexage et quantification dans pcr avec exigences et matériel réduits
US20140100126A1 (en) 2012-08-17 2014-04-10 Natera, Inc. Method for Non-Invasive Prenatal Testing Using Parental Mosaicism Data
PL4026917T3 (pl) 2014-04-14 2024-04-08 Yissum Research And Development Company Of The Hebrew University Of Jerusalem Ltd. Metoda i zestaw do określania śmierci komórek lub tkanek albo tkankowego lub komórkowego pochodzenia dna za pomocą analizy metylacji dna
EP2942400A1 (fr) * 2014-05-09 2015-11-11 Lifecodexx AG Détection multiplexe d'ADN qui provient d'un type cellulaire spécifique
DK3543356T3 (da) 2014-07-18 2021-10-11 Univ Hong Kong Chinese Analyse af methyleringsmønster af væv i DNA-blanding
CN113186288A (zh) 2015-02-24 2021-07-30 兹莫研究公司 测定dna甲基化的分析法和癌症的dna甲基化标记
EP4428863A2 (fr) 2015-05-11 2024-09-11 Natera, Inc. Procédés et compositions pour déterminer la ploïdie
TWI767888B (zh) * 2015-09-22 2022-06-21 香港中文大學 藉由母體血漿dna之淺深度測序以準確定量胎兒dna含量
KR102522067B1 (ko) * 2016-05-03 2023-04-13 유니버시티 헬스 네트워크 무-세포 메틸화된 dna의 포획 방법 및 이의 이용
KR102482616B1 (ko) 2016-05-30 2022-12-28 더 차이니즈 유니버시티 오브 홍콩 혈액 내 무세포 dna를 사용하는 혈액 장애의 검출
AU2017347790B2 (en) 2016-10-24 2024-06-13 Grail, Inc. Methods and systems for tumor detection
CA3042696A1 (fr) * 2016-11-02 2018-05-11 The Medical College Of Wisconsin, Inc. Procedes d'evaluation du risque a l'aide d'adn acellulaire total et specifique
KR20230062684A (ko) * 2016-11-30 2023-05-09 더 차이니즈 유니버시티 오브 홍콩 소변 및 기타 샘플에서의 무세포 dna의 분석
EP4421489A2 (fr) 2017-01-25 2024-08-28 The Chinese University of Hong Kong Applications diagnostiques utilisant des fragments d'acide nucléique
CA3067637A1 (fr) 2017-06-20 2018-12-27 The Medical College Of Wisconsin, Inc. Evaluation du risque de complication d'une greffe avec l'adn acellulaire total
WO2019010564A1 (fr) 2017-07-12 2019-01-17 University Health Network Détection et classification de cancer à l'aide d'analyse de méthylome
EP3652344A1 (fr) 2017-07-13 2020-05-20 Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. Cibles d'adn à titre de marqueurs de méthylation spécifiques de tissu
US20200165671A1 (en) 2017-07-13 2020-05-28 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Detecting tissue-specific dna
EP3652343A1 (fr) 2017-07-13 2020-05-20 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Stratégie de pcr en gouttelettes à double sonde pour la détection spécifique de molécules d'adn circulantes spécifiques d'un tissu
WO2019118926A1 (fr) 2017-12-14 2019-06-20 Tai Diagnostics, Inc. Évaluation de la compatibilité d'une greffe pour la transplantation
EP3766076A4 (fr) * 2018-03-15 2021-12-29 Grail, Inc. Marqueur de méthylation spécifique au tissu
EP3781714A1 (fr) 2018-04-14 2021-02-24 Natera, Inc. Procédés de détection et de surveillance du cancer au moyen d'une détection personnalisée d'adn tumoral circulant
CN112424377A (zh) * 2018-04-17 2021-02-26 克罗玛科德公司 用于多重分析的方法和系统
US20190385700A1 (en) * 2018-06-04 2019-12-19 Guardant Health, Inc. METHODS AND SYSTEMS FOR DETERMINING The CELLULAR ORIGIN OF CELL-FREE NUCLEIC ACIDS
CN109385464A (zh) * 2018-07-27 2019-02-26 中山大学附属第六医院 一种dna甲基化检测试剂盒及方法
CN109706242A (zh) * 2019-01-31 2019-05-03 佛山市顺德区辉锦创兴生物医学科技有限公司 心肌细胞受损检测试剂盒及其应用
US11931674B2 (en) 2019-04-04 2024-03-19 Natera, Inc. Materials and methods for processing blood samples
WO2020264051A1 (fr) * 2019-06-24 2020-12-30 ChromaCode, Inc. Procédés de quantification différentielle d'acides aminés
CN112176419B (zh) * 2019-10-16 2022-03-22 中国医学科学院肿瘤医院 一种检测ctDNA中肿瘤特异基因的变异和甲基化的方法
KR20220092561A (ko) * 2019-10-31 2022-07-01 메이오 파운데이션 포 메디칼 에쥬케이션 앤드 리써치 난소암 검출
AU2020378435A1 (en) * 2019-11-06 2022-05-26 The Board Of Trustees Of The Leland Stanford Junior University Methods and systems for analyzing nucleic acid molecules
CN113249458B (zh) * 2020-02-10 2023-07-07 北京优乐复生科技有限责任公司 一种预测胎盘源性疾病的评估和预测的方法和试剂盒
CN112662761A (zh) * 2020-03-05 2021-04-16 博尔诚(北京)科技有限公司 一种检测3种实质性器官肿瘤的探针组合物
US11817187B2 (en) * 2020-05-18 2023-11-14 TMRW Life Sciences, Inc. Handling and tracking of biological specimens for cryogenic storage
CN111763725A (zh) * 2020-07-02 2020-10-13 济南国科医工科技发展有限公司 用于21-三体风险检测的试剂盒
RU2738680C1 (ru) * 2020-08-07 2020-12-15 Федеральное государственное автономное образовательное учреждение высшего образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") Способ прогнозирования риска развития синдрома задержки роста плода у женщин без отягощенного семейного анамнеза с использованием молекулярно-генетических данных
JP7545768B2 (ja) 2020-10-02 2024-09-05 ティーエムアールダブリュ ライフサイエンシーズ,インコーポレイテツド 無線トランスポンダタグ付き試料容器及び/又はキャリアのための位置合わせ機構を有する問い合わせ装置及び/又はシステム
WO2023133572A2 (fr) * 2022-01-10 2023-07-13 Washington State University Biomarqueurs de méthylation d'adn pour la naissance prématurée
WO2023227954A1 (fr) * 2022-05-22 2023-11-30 Nucleix Ltd. Préparation d'échantillon pour analyse d'adn acellulaire
US20240084374A1 (en) * 2022-09-13 2024-03-14 Bio-Rad Laboratories, Inc. Method for estimation of fetal fraction in cell-free dna from maternal sample
CN118621020A (zh) * 2024-08-15 2024-09-10 广东辉锦创兴生物医学科技有限公司 鼻咽癌诊断或鉴别的甲基化分子标志物、试剂盒及其应用

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5210015A (en) 1990-08-06 1993-05-11 Hoffman-La Roche Inc. Homogeneous assay system using the nuclease activity of a nucleic acid polymerase
US5994056A (en) 1991-05-02 1999-11-30 Roche Molecular Systems, Inc. Homogeneous methods for nucleic acid amplification and detection
US5538848A (en) 1994-11-16 1996-07-23 Applied Biosystems Division, Perkin-Elmer Corp. Method for detecting nucleic acid amplification using self-quenching fluorescence probe
EP0706649B1 (fr) 1994-04-29 2001-01-03 Perkin-Elmer Corporation Procede et dispositif de detection en temps reel de produits d'amplification d'acides nucleiques
US6017704A (en) 1996-06-03 2000-01-25 The Johns Hopkins University School Of Medicine Method of detection of methylated nucleic acid using agents which modify unmethylated cytosine and distinguishing modified methylated and non-methylated nucleic acids
US5786146A (en) 1996-06-03 1998-07-28 The Johns Hopkins University School Of Medicine Method of detection of methylated nucleic acid using agents which modify unmethylated cytosine and distinguishing modified methylated and non-methylated nucleic acids
DE19906169A1 (de) 1999-02-08 2000-08-10 Bioinside Ges Fuer Biodiagnost Testkit und Verfahren zum quantitativen Nachweis von gentechnisch veränderter DNS in Lebensmitteln mittels fluoreszenzgekoppelter PCR
US6331393B1 (en) 1999-05-14 2001-12-18 University Of Southern California Process for high-throughput DNA methylation analysis
US6727356B1 (en) 1999-12-08 2004-04-27 Epoch Pharmaceuticals, Inc. Fluorescent quenching detection reagents and methods
US6929907B2 (en) 1999-12-31 2005-08-16 North Carolina State University Methods and compositions for determining the purity of chemically synthesized nucleic acids
US6927028B2 (en) * 2001-08-31 2005-08-09 Chinese University Of Hong Kong Non-invasive methods for detecting non-host DNA in a host using epigenetic differences between the host and non-host DNA
US20030165859A1 (en) 2001-10-23 2003-09-04 Invitrogen Corporation Primers and methods for the detection and discrimination of nucleic acids
WO2003062441A1 (fr) 2002-01-18 2003-07-31 Genzyme Corporation Procedes de detection d'adn foetal et de quantification d'alleles
US20040229211A1 (en) 2003-05-13 2004-11-18 Yeung Wah Hin Alex Sensitive diagnostic testing methodology using multiplex real time PCR with one dye (MOD) and its use as in severe acute respiratory syndrome (SARS)
US7655399B2 (en) 2003-10-08 2010-02-02 Trustees Of Boston University Methods for prenatal diagnosis of chromosomal abnormalities
EP1524321B2 (fr) 2003-10-16 2014-07-23 Sequenom, Inc. Détection non invasive de traits génétiques létaux
EP1692264A2 (fr) 2003-10-28 2006-08-23 The Johns Hopkins University Pcr quantitative multiplex specifique de la methylation
JP2005261354A (ja) 2004-03-19 2005-09-29 Arkray Inc 核酸の蛍光検出法
DK1735459T3 (da) 2004-04-07 2012-05-29 Exiqon As Fremgangsmåder til kvantificering af microRNA'er og små interfererende RNA'er
US7709194B2 (en) 2004-06-04 2010-05-04 The Chinese University Of Hong Kong Marker for prenatal diagnosis and monitoring
US20070059753A1 (en) 2005-09-15 2007-03-15 Tatiana Vener Detecting gene methylation
US7901884B2 (en) 2006-05-03 2011-03-08 The Chinese University Of Hong Kong Markers for prenatal diagnosis and monitoring
US7754428B2 (en) 2006-05-03 2010-07-13 The Chinese University Of Hong Kong Fetal methylation markers
US8679741B2 (en) 2006-05-31 2014-03-25 Sequenom, Inc. Methods and compositions for the extraction and amplification of nucleic acid from a sample
WO2008128198A2 (fr) * 2007-04-12 2008-10-23 Usc Stevens - University Of Southern California Analyse de la méthylation d'un adn au moyen d'un séquençage numérique au bisulfite et de la méthode methylight numérique
DK2329021T3 (en) 2008-09-16 2016-10-24 Sequenom Inc Methods and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample suitable for non-invasive prenatal diagnoses
US8476013B2 (en) 2008-09-16 2013-07-02 Sequenom, Inc. Processes and compositions for methylation-based acid enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
US20120252015A1 (en) 2011-02-18 2012-10-04 Bio-Rad Laboratories Methods and compositions for detecting genetic material
US8563242B2 (en) 2009-08-11 2013-10-22 The Chinese University Of Hong Kong Method for detecting chromosomal aneuploidy
PL2529032T3 (pl) * 2010-01-26 2017-07-31 Nipd Genetics Ltd Sposoby i kompozycje do nieinwazyjnego prenatalnego diagnozowania aneuploidii płodu
WO2012007783A1 (fr) 2010-07-13 2012-01-19 Institut Gustave Roussy Trousses et procédés de détection de la capacité à induire une mort cellulaire cancéreuse immunogène chez un patient
US8603742B2 (en) 2010-07-06 2013-12-10 University of Pittsburgh—of the Commonwealth System of Higher Education Methods for the diagnosis of fetal disease
CA2802111A1 (fr) * 2010-07-23 2012-01-26 Esoterix Genetic Laboratories, Llc Identification de regions genomiques foetales ou maternelles differentiellement representees et ses utilisations
CA2806291C (fr) * 2010-07-23 2023-08-29 President And Fellows Of Harvard College Procedes de detection de signatures de maladies ou pathologies dans des liquides biologiques
US20120034603A1 (en) 2010-08-06 2012-02-09 Tandem Diagnostics, Inc. Ligation-based detection of genetic variants
WO2012092599A1 (fr) 2010-12-30 2012-07-05 Agco Corporation Évaluation en temps réel des performances d'une machine pour la gestion d'une flotte
CA2834218C (fr) 2011-04-29 2021-02-16 Sequenom, Inc. Quantification d'une minorite d'especes d'acide nucleique utilisant des oligonucleotides inhibiteurs
US10196681B2 (en) 2011-10-06 2019-02-05 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
DK2768978T3 (en) * 2011-10-18 2017-12-18 Multiplicom Nv Fetal CHROMOSOMAL ANEUPLOIDID DIAGNOSIS
US9892230B2 (en) 2012-03-08 2018-02-13 The Chinese University Of Hong Kong Size-based analysis of fetal or tumor DNA fraction in plasma
JP2015521862A (ja) 2012-07-13 2015-08-03 セクエノム, インコーポレイテッド 非侵襲性の出生前診断に有用な母体サンプル由来の胎児核酸のメチル化に基づく富化のためのプロセスおよび組成物
ES2665273T5 (es) 2012-09-20 2023-10-02 Univ Hong Kong Chinese Determinación no invasiva de metiloma del feto o tumor de plasma
CA2887094C (fr) 2012-10-04 2021-09-07 Sequenom, Inc. Procedes et processus d'evaluation non invasive de variations genetiques
EP2971100A1 (fr) 2013-03-13 2016-01-20 Sequenom, Inc. Amorces pour analyse de la méthylation de l'adn
US10017824B2 (en) 2013-07-30 2018-07-10 Bgi Genomics Co., Limited Method for determining nucleic acid composition of nucleic acid mixture
WO2015138774A1 (fr) 2014-03-13 2015-09-17 Sequenom, Inc. Méthodes et procédés d'évaluation non invasive de variations génétiques
EP2942400A1 (fr) * 2014-05-09 2015-11-11 Lifecodexx AG Détection multiplexe d'ADN qui provient d'un type cellulaire spécifique
EP2942401A1 (fr) * 2014-05-09 2015-11-11 Lifecodexx AG Détection d'ADN qui provient d'un type cellulaire spécifique
WO2017220156A1 (fr) 2016-06-23 2017-12-28 Trisomytest, S.R.O. Procédé de détection prénatale non invasive de l'aneuploïdie chromosomique fœtale à partir du sang maternel

Also Published As

Publication number Publication date
CN107223159A (zh) 2017-09-29
IL248637A0 (en) 2017-01-31
WO2015169947A9 (fr) 2015-12-30
EP3140421B8 (fr) 2020-05-06
US20200407793A1 (en) 2020-12-31
RU2016147914A3 (fr) 2018-12-27
JP2017514499A (ja) 2017-06-08
CA2985134A1 (fr) 2015-11-12
AU2015257654A1 (en) 2016-11-10
RU2016147914A (ru) 2018-06-18
US10801067B2 (en) 2020-10-13
US11965207B2 (en) 2024-04-23
EP3140421B1 (fr) 2020-03-25
SG11201608993RA (en) 2016-11-29
US20170314073A1 (en) 2017-11-02
WO2015169947A1 (fr) 2015-11-12
EP3140421A1 (fr) 2017-03-15
EP3521454A1 (fr) 2019-08-07
JP6681841B2 (ja) 2020-04-15

Similar Documents

Publication Publication Date Title
MA39951A (fr) Détection de l'adn provenant d'un type spécifique de cellule et méthodes associées
BR112018008532A2 (pt) detecção de aneuploidias cromossômicas do feto usando regiões de dna que são metiladas de forma diferenciada entre o feto e a mulher grávida
MY195527A (en) Methods And Systems For Tumor Detection
MX2016016902A (es) Metodos para analizar acidos nucleicos de celulas individuales o poblaciones de celulas.
EP3744859A3 (fr) Biomarqueur à base de microarn utilisable en vue du diagnostic du cancer gastrique
EP4382613A3 (fr) Analyse basée sur la taille de fraction d'adn f tal dans du plasma maternel
WO2014151764A3 (fr) Procédés et compositions pour classification d'échantillons
BR112015032031A8 (pt) método para estimar uma fração de ácido nucleico em uma amostra de teste de uma mulher grávida
GB2519906A (en) Methods and systems for detecting biological components
MX2021006791A (es) Metodos y composiciones para detectar proteinas mal plegadas.
EP4219765A3 (fr) Pronostic du cancer de la prostate à l'aide de biomarqueurs
EP2576837A4 (fr) Biomarqueurs d'acides nucléiques circulants associés au cancer de la prostate
TW201129736A (en) Size-based genomic analysis
AR105618A1 (es) Metilación del promotor del ligando al receptor de muerte programada (pd-l1) en cáncer
MY192493A (en) Urinalysis device and dry reagent for quantitative urinalysis
WO2009114543A3 (fr) Tests adn pour déterminer le sexe d'un bébé avant sa naissance
EP3654036A3 (fr) Biomarqueur du cancer de l'estomac et procédé de détection
MX355416B (es) Biomarcadores de cancer de pulmon y usos de los mismos.
MX2019010844A (es) Analisis del transcriptoma de plasma materno mediante secuenciacion de arn en paralelo a gran escala.
WO2020055954A3 (fr) Méthodes de détection de maladies hépatiques
WO2018097614A3 (fr) Méthode de prédiction de l'efficacité d'une chimiothérapie chez des patientes atteintes d'un cancer du sein
WO2011113047A3 (fr) Compositions et méthodes permettant de caractériser le cancer du sein
WO2014184679A3 (fr) Procédé de pronostic et de traitement de la métastase d'un carcinome des cellules rénales
WO2015095862A3 (fr) Biomarqueurs de micro-arn pour le cancer de l'ovaire
WO2013112836A3 (fr) Biomarqueurs diagnostiques et pronostiques du cancer